These data indicate that under the applied experimental conditions only the bivalent α-EGFR-EGFR TM was able to successfully redirect UniCAR-armed T cells against EGFR-positive tumor cells in vivo thus underlining the superiority of the bivalent α-EGFR-EGFR TM. Here, EGFR is linked to neoplasm.